scispace - formally typeset
D

David Favre

Researcher at University of California, San Francisco

Publications -  17
Citations -  2277

David Favre is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Simian immunodeficiency virus & Immune system. The author has an hindex of 15, co-authored 16 publications receiving 2152 citations. Previous affiliations of David Favre include French Institute of Health and Medical Research.

Papers
More filters
Journal ArticleDOI

Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease.

TL;DR: Patients with AIDS have fewer immune cells to defend against microbial invasion through the gut, a critical loss that may be caused by a tryptophan metabolite produced by other immune cells, and IDO1 inhibitors are being tested for their efficacy in interfering with this dangerous depletion of defenses.
Journal ArticleDOI

Factors influencing recombinant adeno-associated virus production.

TL;DR: A general method to titrate rAAV, independently of the transgene and its expression, and to measure the level of contamination with adenovirus and rep-positive AAV is described.
Journal ArticleDOI

Phenotypic, Functional, and Kinetic Parameters Associated with Apparent T-Cell Control of Human Immunodeficiency Virus Replication in Individuals with and without Antiretroviral Treatment

TL;DR: Control of HIV replication is associated with high levels of HIV-specific IL-2+ and IFN-γ+ CD4+ T cells and low levels of T-cell activation, suggesting that functional immunity can be reconstituted with partially suppressive highly active antiretroviral therapy.
Journal ArticleDOI

Th17 and regulatory T cells: implications for AIDS pathogenesis.

TL;DR: It remains unclear, however, whether Th17 cells are preferentially infected or if, instead, their loss is induced by bystander effects of lentiviral infection, for example, the induction of indoleamine 2,3-dioxygenase.